Literature DB >> 9810511

Cell proliferation and cancer.

J F López-Sáez1, C de la Torre, J Pincheira, G Giménez-Martín.   

Abstract

The discovery that phosphorylation of selected proteins by cyclin-dependent kinases is the engine which makes the cycle run provides a new image of the control of proliferation and of its deregulation. The high conservation of this machinery in the different eukaryotic organisms emphasizes its early origin and its importance for life. It also makes the extrapolation of findings between different species feasible. The control of proliferation relies basically on accelerating and braking mechanisms which act on the engine driving the cycle. This review particularly stresses the importance of checkpoint or tumor suppressor pathways as transduction systems of negative signals which may induce a cycle braking operation. They prevent any important cycle transition, as the initiation of proliferation, that of replication, mitosis, etc., until the DNA and other cellular conditions make such a progression safe. These checkpoint pathways are able to recognize and transduce signals about the adequacy of initiating or continuing proliferation for a cell at a particular time, under a particular set of external and internal conditions. Crucial components of these pathways are proteins encoded by some of the checkpoint genes that evaluate the final balance of mitogenic and antimitogenic pathways reaching them and, if the balance is negative, they prevent temporarily cycle inititation or its progression by inhibiting the corresponding cyclin-dependent kinases. On the other hand, when the balance becomes positive, they allow the activation of the cyclin-dependent kinases. Uncontrolled cell proliferation associated with cancer always depends on the functional abrogation of at least one of the checkpoint pathways. The checkpoint or tumor suppressor protein p53 is one of the proteins in them, and mutations in the gene encoding it are present in more than half of all human tumours. The review touches new pharmacological strategies which have been opened by the discovery of portions of some of the signal transduction cascades involved in the transient brake of cell proliferation. Restoration of checkpoint pathways either prevents further proliferation of cells with damaged genome until repair is over or, alternatively, the dismantling of these checkpoints induce those cells to commit suicide (apoptosis). The fact that both restoration and dismantling of checkpoint pathways sensitive to DNA damage have not disturbing effects on any other proliferating cell with undamaged DNA makes these selective strategies promissing.

Entities:  

Mesh:

Year:  1998        PMID: 9810511     DOI: 10.14670/HH-13.1197

Source DB:  PubMed          Journal:  Histol Histopathol        ISSN: 0213-3911            Impact factor:   2.303


  22 in total

1.  Regulation and disregulation of mammalian nucleotide excision repair: a pathway to nongermline breast carcinogenesis.

Authors:  Jean J Latimer; Vongai J Majekwana; Yashira R Pabón-Padín; Manasi R Pimpley; Stephen G Grant
Journal:  Photochem Photobiol       Date:  2014-12-19       Impact factor: 3.421

2.  Induction of Fas-mediated extrinsic apoptosis, p21WAF1-related G2/M cell cycle arrest and ROS generation by costunolide in estrogen receptor-negative breast cancer cells, MDA-MB-231.

Authors:  Youn Kyung Choi; Hye Sook Seo; Han Seok Choi; Hyeong Sim Choi; Soon Re Kim; Yong Cheol Shin; Seong-Gyu Ko
Journal:  Mol Cell Biochem       Date:  2011-12-07       Impact factor: 3.396

3.  Synergistic effects of laminin-1 peptides, VEGF and FGF9 on salivary gland regeneration.

Authors:  Kihoon Nam; Spencer M Dean; Callie T Brown; Randall J Smith; Pedro Lei; Stelios T Andreadis; Olga J Baker
Journal:  Acta Biomater       Date:  2019-04-25       Impact factor: 8.947

4.  Caffeine does not enhance radiosensitivity of normal liver tissue in vivo.

Authors:  Tie-Jun Wang; Zhong-Shan Liu; Zhao-Chong Zeng; Shi-Suo Du; Ming Qiang; Wei Jiang; Le-Yuan Zhou; Wei-Jie Ding; Hai-Ying Zeng
Journal:  Mol Biol Rep       Date:  2010-11-30       Impact factor: 2.316

5.  Pien Tze Huang inhibits the proliferation of colorectal cancer cells by increasing the expression of miR-34c-5p.

Authors:  Yun Wan; Aling Shen; Fei Qi; Jianfeng Chu; Qiaoyan Cai; Thomas Joseph Sferra; Jun Peng; Youqin Chen
Journal:  Exp Ther Med       Date:  2017-08-18       Impact factor: 2.447

6.  Long non-coding RNA LINC00243 promotes proliferation and glycolysis in non-small cell lung cancer cells by positively regulating PDK4 through sponging miR-507.

Authors:  Xuegang Feng; Shengsheng Yang
Journal:  Mol Cell Biochem       Date:  2019-10-08       Impact factor: 3.396

7.  Diallyl disulfide-induced G2/M arrest of human gastric cancer MGC803 cells involves activation of p38 MAP kinase pathways.

Authors:  Jing-Ping Yuan; Gui-Hua Wang; Hui Ling; Qi Su; Yue-Hong Yang; Ying Song; Rong-Jun Tang; Yao Liu; Chen Huang
Journal:  World J Gastroenterol       Date:  2004-09-15       Impact factor: 5.742

8.  The construction and proliferative effects of a lentiviral vector capable of stably overexpressing SPINK1 gene in human pancreatic cancer AsPC-1 cell line.

Authors:  Jing Zhang; Dongmei Wang; Na Hu; Qian Wang; Shanice Yu; Jun Wang
Journal:  Tumour Biol       Date:  2015-11-19

9.  Transcriptome and physiological effects of toxaphene on the liver-gonad reproductive axis in male and female largemouth bass (Micropterus salmoides).

Authors:  Christopher J Martyniuk; Alvine C Mehinto; Reyna Cristina Colli-Dula; Kevin J Kroll; Nicholas J Doperalski; David S Barber; Nancy D Denslow
Journal:  Comp Biochem Physiol Part D Genomics Proteomics       Date:  2020-09-19       Impact factor: 2.674

10.  SDCBP/MDA-9/syntenin phosphorylation by AURKA promotes esophageal squamous cell carcinoma progression through the EGFR-PI3K-Akt signaling pathway.

Authors:  Ruijuan Du; Chuntian Huang; Hanyong Chen; Kangdong Liu; Pu Xiang; Ning Yao; Lu Yang; Liting Zhou; Qiong Wu; Yaqiu Zheng; Mingxia Xin; Zigang Dong; Xiang Li
Journal:  Oncogene       Date:  2020-06-22       Impact factor: 9.867

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.